{"SPADE_N_05041": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2006/0122119 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2006_0122119_A1", "Patent Type": "Patent Application", "Publication Date": "2006-6-8", "Family Info": "CA2477762A1,EP1481009A2,WO2003074565A2,WO2003074565A3", "Patent Title": "Peptides for use in antitumor immunotherapy.", "Abstract": "The invention concerns the use of immunogenic peptides representing T epitopes presented by the MHC I, derived from Melan-A, MAGE-A6, gp 100, tyrosinase and NY-ESO-1 antigens for the diagnosis or treatment of melanomas in HLA-B35 subjects."}], "Sequence Information": {"SPADE ID": "SPADE_N_05041", "Sequence": "TPRLPSSADVEFCL", "Sequence Length": 14, "Peptide Name": "Sequence 14 from Patent US 20060122119", "Source": "Homo sapiens", "Biological Activity": ["Antitumor"], "Frequent Amino Acids": "LPS", "Absent Amino Acids": "GHIKMNOQUWY", "Basic Residues": 1, "Acidic Residues": 2, "Hydrophobic Residues": 7, "Polar Residues": 7, "Positive Residues": 1, "Negative Residues": 2, "Mass": 1534.73, "PI": 4.37, "Net Charge": -1, "Hydrophobicity": 0.14, "Similar Sequences": [{"SPADE_ID": "SPADE_N_05035", "Similarity": 1.0, "Sequence": "TPRLPSSADVEF"}, {"SPADE_ID": "SPADE_N_05052", "Similarity": 1.0, "Sequence": "TPRLPSSADVEFC"}, {"SPADE_ID": "SPADE_N_05053", "Similarity": 1.0, "Sequence": "TPRLPSSADVE"}]}}}